Evidence map›Paper›PMID 30858878›Full record

ArticleBiotechnology for biofuels2019

Engineering

Yusuke Sasaki, Thomas Eng, Robin A Herbert, Jessica Trinh, Yan Chen, Alberto Rodriguez, John Gladden, Blake A Simmons, Christopher J Petzold, Aindrila Mukhopadhyay

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 82 citations in OpenAlex.

  1. Multi-layered metabolic remodeling ofMetabolic engineering communications · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Enabling and improvingFrontiers in bioengineering and biotechnology · 2025
    Article
  10. Article
  11. Utilization of orange peel waste for sustainable amino acid production byFrontiers in bioengineering and biotechnology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Microbial production of advanced biofuels.Nature reviews. Microbiology · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yusuke Sasaki *1Graduate School of Advanced Integrated Studies in Human Survivability, Kyoto University, Sakyo-ku, Kyoto, Japan.
Thomas Eng *3Joint BioEnergy Institute, Emeryville, CA USA.
Robin A Herbert3Joint BioEnergy Institute, Emeryville, CA USA.
Jessica Trinh3Joint BioEnergy Institute, Emeryville, CA USA.
Yan Chen3Joint BioEnergy Institute, Emeryville, CA USA.
Alberto Rodriguez3Joint BioEnergy Institute, Emeryville, CA USA.
John Gladden3Joint BioEnergy Institute, Emeryville, CA USA.
Blake A Simmons3Joint BioEnergy Institute, Emeryville, CA USA.ORCID 0000-0002-1332-1810
Christopher J Petzold3Joint BioEnergy Institute, Emeryville, CA USA.
Aindrila Mukhopadhyay3Joint BioEnergy Institute, Emeryville, CA USA.ORCID 0000-0002-6513-7425
Lawrence Berkeley National Laboratory · USSandia National Laboratories California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany microbes used for the rapid discovery and development of metabolic pathways have sensitivities to final products and process reagents. Isopentenol (3-methyl-3-buten-1-ol), a biogasoline candidate, has an established heterologous gene pathway but is toxic to several microbial hosts. Reagents used in the pretreatment of plant biomass, such as ionic liquids, also inhibit growth of many host strains. We explored the use of

resultsWe found

conclusionsWe describe the successful expression of a heterologous mevalonate-based pathway in the Gram-positive industrial microorganism,

Indexed as

3-Methyl-3-buten-1-olCorynebacterium glutamicumHmgRHydrolysateIonic liquid pretreatmentIsopentenolIsoprenolSorghum

Identifiers

PMID30858878
PMCPMC6391826
OpenAlexW2923874169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.